HURA
トゥフラ・バイオサイエンシズ
TuHURA Biosciences, Inc.
閉場中RVOL 1.3xDV $535,46120日平均DV $428,629?
Earnings 2026-11-1352W high -42.3%52W low +382.9%Fwd PER 99.0xMarket cap $134MAvg volume 215K
Company Overview
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q2 | -0.14 | $0 | -$9M |
| 2026 Q1 | -0.13 | $0 | -$4M |
| 2025 Q4 | -0.13 | $0 | -$6M |
| 2025 Q3 | -0.14 | $0 | -$11M |
| 2025 Q2 | -0.21 | $0 | -$6M |
| 2025 Q1 | -0.15 | $0 | -$5M |
| 2024 Q4 |
